| Serial Number | 97778211 |
| Word Mark | CULLINAN |
| Filing Date | Thursday, February 2, 2023 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Friday, September 20, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical products for the prevention and treatment of cancer; therapeutic pharmaceuticals for the treatment of cancer; anti-cancer preparations being anti-cancer medicines comprised of small molecules and biologics; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer and for use in the fields of oncology and immunology |
| Goods and Services | Pharmaceutical research and development; scientific research and development; medical research and development; medical research and development services in the fields of drug discovery and oncology |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 21, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 8, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CULLINAN THERAPEUTICS, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CAMBRIDGE, MA 02142 |
| Party Name | Cullinan Oncology, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Tuesday, February 21, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 31, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, November 7, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 7, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, November 7, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, February 7, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 7, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 8, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 5, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 5, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, March 7, 2024 | FINAL REFUSAL WRITTEN |
| Thursday, March 7, 2024 | FINAL REFUSAL E-MAILED |
| Thursday, March 7, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, June 5, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, June 5, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, September 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, September 20, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, September 20, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, September 20, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 25, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |